ScholarIQanswers from OpenAlex & ORCID
Ian Ford
ResearcherPublications, citations & collaboration network
Ian Ford is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ian Ford have?
ScholarIQindexed works
Ian Ford has 640 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ian Ford have?
ScholarIQcitation count
Ian Ford has 69,938 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ian Ford?
ScholarIQh-index
Ian Ford has an h-index of 120 in OpenAlex.
What is the i10-index of Ian Ford?
ScholarIQi10-index
Ian Ford has an i10-index of 364 in OpenAlex.
What is the ORCID of Ian Ford?
ScholarIQorcid
The ORCID for Ian Ford is on the source record.
What is the OpenAlex record for Ian Ford?
ScholarIQopenalex
The OpenAlex for Ian Ford is on the source record.
What are the most-cited papers on Ian Ford?
ScholarIQmost cited works
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
James Shepherd, Stuart M. Cobbe, Ian Ford, Christopher Isles, A R Lorimer, Peter W. Macfarlane, James H. McKillop, Christopher J. Packard
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
James Shepherd, Gerard J. Blauw, Michael Murphy, Edward Bollen, Brendan M. Buckley, Stuart M. Cobbe, Ian Ford, Allan Gaw, Michael E. Hyland, J. Wouter Jukema, Adriaan M. Kamper, Peter W. Macfarlane, A. Edo Meinders, John Norrie, Chris J. Packard, Ivan J. Perry, David J. Stott, Brian Sweeney, Gillian Twomey, Rudi GJ Westendorp
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy
Christian Templin, Jelena R. Ghadri, Johanna Diekmann, L. Christian Napp, Dana Roxana Bataiosu, Miłosz Jaguszewski, Victoria L. Cammann, Annahita Sarcon, V. Geyer, Catharina A. Neumann, Burkhardt Seifert, Jens Hellermann, Moritz Schwyzer, Katharina Eisenhardt, Josef Jenewein, Jennifer Franke, Hugo A. Katus, Christof Burgdorf, Heribert Schunkert, Christian Moeller, Hölger Thiele, Johann Bauersachs, Carsten Tschöpe, Heinz‐Peter Schultheiß, C. Laney, Lawrence Rajan, Guido Michels, Roman Pfister, Christian Ukena, Michael Böhm, Raimund Erbel, Alessandro Cuneo, Karl Heinz Kuck, Claudius Jacobshagen, Gerd Hasenfuß, Mahir Karakas, Wolfgang Köenig, Wolfgang Rottbauer, Samir M. Said, Ruediger C. Braun‐Dullaeus, Florim Cuculi, Adrian Banning, Thomas Fischer, Tuija Vasankari, Juhani Airaksinen, Marcin Fijałkowski, Andrzej Rynkiewicz, Maciej Pawlak, Grzegorz Opolski, Rafał Dworakowski, Philip MacCarthy, Christoph Kaiser, Stefan Osswald, Leonarda Galiuto, Filippo Crea, Wolfgang Dichtl, Wolfgang M. Franz, Klaus Empen, Stephan B. Felix, Clément Delmas, Olivier Lairez, Paul Erné, Jeroen J. Bax, Ian Ford, Frank Ruschitzka, Abhiram Prasad, Thomas F. Lüscher
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar, David Preiss, Heather Murray, Paul Welsh, Brendan M. Buckley, Anton JM de Craen, Sreenivasa Rao Kondapally Seshasai, John J.V. McMurray, Dilys J. Freeman, J. Wouter Jukema, Peter W. Macfarlane, Chris J. Packard, David J. Stott, Rudi G. J. Westendorp, James Shepherd, Barry R. Davis, Sara Pressel, Roberto Marchioli, Rosa Maria Marfisi, Aldo P. Maggioni, Luigi Tavazzi, Gianni Tognoni, John Kjekshus, Terje R. Pedersen, Thomas J. Cook, Antonio M. Gotto, Michael Clearfield, John R. Downs, Haruo Nakamura, Yasuo Ohashi, Kyoichi Mizuno, Kausik K. Ray, Ian Ford
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
Michael EJ Lean, W. S. Leslie, Alison C. Barnes, Naomi Brosnahan, George Thom, Louise McCombie, Carl Peters, Sviatlana Zhyzhneuskaya, Ahmad Al-Mrabeh, Kieren G. Hollingsworth, Angela Rodrigues, Lucia Rehackova, Ashley Adamson, Falko F. Sniehotta, John C. Mathers, H. M. Ross, Yvonne McIlvenna, Renae J. Stefanetti, Michael I. Trenell, Paul Welsh, Sharon Kean, Ian Ford, Alex McConnachie, Naveed Sattar, Roy Taylor